EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
Selection, Procurement and Distribution
Catarina Diogo, Rui Caceiro, Ana Soares, Maria Helena Duarte, Armando Alcobia
The Pharmacy and Therapeutics Committees (PTCs) of hospitals and local health units ensure the quality and safety of medications, while also contributing to improved stock management and cost reduction. In our hospital, over the past five years, the PTC has held an average of 49 meetings per year, reviewing 792 drug use requests annually, with an approval rate of 95.4%. However, the current procedure, which relies on email-based requests for new drug authorizations, is disjointed and prone to errors, requiring constant and full-time involvement of the responsible pharmacists. Recognizing that technological innovation is essential in optimizing processes within healthcare services, and inspired by the success of the NOA-Digital application, the opportunity arose to develop a new application, this time for the PTC.
Development of a software specifically designed to simplify the authorization request process for new drugs.
A software was development using the Power Apps platform. Between January and May 2024, the needs of the PTC were assessed by gathering input from the participating pharmacists. Subsequently, a software application was developed, allowing for the submission of new authorization requests, the creation of meeting agendas, the review, deliberation, and communication of approval results to the responsible physician, the drafting of meeting minutes, the monitoring of newly approved drugs, as well as access to the status of requests and previous minutes.
The authors believe that this software allows for a more efficient, convenient, and integrated workflow compared to the current email-based system, which is more complex and prone to errors. From a pharmaceutical perspective, this alternative simplifies the workflow, ensuring better access to all relevant information without loss, as well as automating certain tasks—such as creating meeting agendas, drafting minutes, and issuing periodic drug monitoring alerts. Additionally, it is also useful for physicians by facilitating the submission of new authorization requests and notifications of the respective deliberations.
This software is expected to transform the PTC’s authorization request process. The systematic use will allow for determining the potential applicability in PTCs of other hospitals.
